Home GSK's breast cancer drug Tykerb fails in gastric cancer study
 

Keywords :   


GSK's breast cancer drug Tykerb fails in gastric cancer study

2013-06-03 14:37:51| Biotech - Topix.net

GlaxoSmithKline said on Monday that its breast cancer drug lapatinib in combination with chemotherapy did not improve survival rates for patients with gastric cancer compared to the use of chemotherapy alone.

Tags: study drug cancer fails

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.09Tropical Storm John Graphics
25.09Tropical Storm John Public Advisory Number 11A
25.09Summary for Tropical Storm John (EP5/EP102024)
25.09Hurricane Helene Public Advisory Number 9A
25.09Summary for Hurricane Helene (AT4/AL092024)
25.09Atlantic Tropical Weather Outlook
25.09Eastern North Pacific Tropical Weather Outlook
25.09Fall calving considerations
More »